Oncogenic alterations of metabolism
- PMID: 10098401
- DOI: 10.1016/s0968-0004(98)01344-9
Oncogenic alterations of metabolism
Abstract
Over seven decades ago, classical biochemical studies showed that tumors have altered metabolic profiles and display high rates of glucose uptake and glycolysis. Although these metabolic changes are not the fundamental defects that cause cancer, they might confer a common advantage on many different types of cancers, which allows the cells to survive and invade. Recent molecular studies have revealed that several of the multiple genetic alterations that cause tumor development directly affect glycolysis, the cellular response to hypoxia and the ability of tumor cells to recruit new blood vessels.
Similar articles
-
Hypoxia and VEGF mRNA expression in human tumors.Neoplasia. 2001 Nov-Dec;3(6):500-8. doi: 10.1038/sj.neo.7900195. Neoplasia. 2001. PMID: 11774032 Free PMC article. Clinical Trial.
-
Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.Cancer Res. 2001 Oct 1;61(19):7349-55. Cancer Res. 2001. PMID: 11585776
-
A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.Jpn J Cancer Res. 2001 Dec;92(12):1342-51. doi: 10.1111/j.1349-7006.2001.tb02159.x. Jpn J Cancer Res. 2001. PMID: 11749701 Free PMC article.
-
The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.Science. 2010 Dec 3;330(6009):1340-4. doi: 10.1126/science.1193494. Science. 2010. PMID: 21127244 Review.
-
Hypoxia-induced regulation of mRNA stability.Adv Exp Med Biol. 2000;475:111-21. doi: 10.1007/0-306-46825-5_11. Adv Exp Med Biol. 2000. PMID: 10849653 Review.
Cited by
-
Acidic tumor microenvironment downregulates hMLH1 but does not diminish 5-fluorouracil chemosensitivity.Mutat Res. 2013 Jul-Aug;747-748:19-27. doi: 10.1016/j.mrfmmm.2013.04.006. Epub 2013 Apr 30. Mutat Res. 2013. PMID: 23643670 Free PMC article.
-
Role of monocarboxylate transporters in human cancers: state of the art.J Bioenerg Biomembr. 2012 Feb;44(1):127-39. doi: 10.1007/s10863-012-9428-1. J Bioenerg Biomembr. 2012. PMID: 22407107 Review.
-
Metabolic modulation of cancer: a new frontier with great translational potential.J Mol Med (Berl). 2015 Feb;93(2):127-42. doi: 10.1007/s00109-014-1250-2. Epub 2015 Jan 14. J Mol Med (Berl). 2015. PMID: 25586106 Review.
-
Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family.J Bioenerg Biomembr. 2007 Feb;39(1):51-7. doi: 10.1007/s10863-006-9061-y. J Bioenerg Biomembr. 2007. PMID: 17549642 Review.
-
Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells.Neuro Oncol. 2010 Nov;12(11):1102-12. doi: 10.1093/neuonc/noq080. Epub 2010 Jul 28. Neuro Oncol. 2010. PMID: 20667897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources